RECORD // Company

CytoDyn Inc.

Formerly: CYTODYN INC; REXRAY CORP

Built 2026-11-21T05:38:47Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • CYTODYN INC. · legal entity in this company's GLEIF ownership tree (LEI 529900Q4JAVBX3H8RF98)
SEC EDGAR (1)
Matched by name only, not merged (6)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • CytoDyn, Inc. · Ctgov · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CYTODYN INC · East licences · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CYTODYN INC. · East licences · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CYTODYN INC. · East licences · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CYTODYN INC. · East licences · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CYTODYN, INC. · East licences · same registered legal name as 'CytoDyn Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-08-31, filed 2026-10-14 · accession 0001175680-26-000035

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-19,936,0003 months ended 2026-08-3110-Q2026-10-140001175680-26-0000352026-11-21 05:38 UTCReport an error
Cash and cash equivalents$16,359,000at 2026-08-3110-Q2026-10-140001175680-26-0000352026-11-21 05:38 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001175680
Ticker
CYDY
EIN
753056237
CUSIP
23283M101
Record ID
sx:sec:0001175680

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

27 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
State of incorporationDE2026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
Fiscal year end (MMDD)05312026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
Business address1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 986602026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
ExchangesOTC2026-11-20SEC EDGAR company profile2026-11-21 05:38 UTCReport an error
Net income (loss) (fiscal year ended 2026-05-31)$-42,699,0002026-05-3110-K, XBRL NetIncomeLoss2026-11-21 05:38 UTCReport an error
Total assets (at 2026-05-31)$13,973,0002026-05-3110-K, XBRL Assets2026-11-21 05:38 UTCReport an error
Stockholders' equity (at 2026-05-31)$-109,718,0002026-05-3110-K, XBRL StockholdersEquity2026-11-21 05:38 UTCReport an error
Cash and cash equivalents (at 2026-05-31)$11,852,0002026-05-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 05:38 UTCReport an error
Operating cash flow (fiscal year ended 2026-05-31)$-17,252,0002026-05-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 05:38 UTCReport an error
Long-term debt (at 2026-05-31)$38,340,0002026-05-3110-K, XBRL LongTermDebt2026-11-21 05:38 UTCReport an error
Operating lease liabilities (at 2026-05-31)$76,0002026-05-3110-K, XBRL OperatingLeaseLiability2026-11-21 05:38 UTCReport an error
Form D total offering amount (D filed 2026-05-11)$18,600,3922026-05-11D2026-11-21 05:38 UTCReport an error
Form D total amount sold (D filed 2026-05-11)$18,600,3922026-05-11D2026-11-21 05:38 UTCReport an error
Form D industry groupPharmaceuticals2026-05-11D2026-11-21 05:38 UTCReport an error
Form D revenue rangeDecline to Disclose2026-05-11D2026-11-21 05:38 UTCReport an error
Form D date of first sale2026-01-302026-05-11D2026-11-21 05:38 UTCReport an error
8-K Item 5.07, Submission of Matters to a Vote of Security Holders (filed 2026-11-20)CytoDyn Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on November 20, 2026. On November 20, 2026, the Inspector of Election issued its final report certifying the final voting results for the Annual Meeting, which were as follows: 1. Election of Directors. Nominee For Withheld Broker Non-Votes Tanya Durkee Urbach 414,695,411 48,299,604 309,846,575 Lishomwa C. Ndhlovu, M.D., Ph.D. 432,454,527 30,540,488 309,846,575 Karen J. Brunke, Ph.D. 430,245,377 32,749,638 309,846,575 Ryan M. Dunlap 432,734,124 30,260,891 309,846,575 Stephen M. Simes 432,202,700 30,792,315 309,846,575 The stockholders elected each of the Company’s director nominees to serve…2026-11-20SEC EDGAR 8-K 0001175680-26-000044 (text as filed, excerpt)2026-11-21 05:38 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-17)A copy of the press release issued by the Company on November 17, 2026, announcing Dr. Wilcoxen’s appointment as the Company’s COO is furnished as Exhibit 99.1.2026-11-17SEC EDGAR 8-K 0001175680-26-000042 (text as filed, excerpt)2026-11-21 05:38 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-10-19)On October 19, 2026, the Company issued a press release announcing the appointment of Mr. Hoffman as the Company’s Chief Executive Officer and related information as described in Item 5.02 above. The press release is furnished as Exhibit 99.1 to this report. Also on October 19, 2026, the Company provided an investor webcast. The slide presentation included with the webcast, which has also been posted on the Company’s website, is furnished as Exhibit 99.2 to this report.2026-10-19SEC EDGAR 8-K 0001175680-26-000038 (text as filed, excerpt)2026-11-21 05:38 UTCReport an error
Largest institutional holder #1 (13F as filed): DIVERSIFIED TRUST CO$10,9342026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error
Largest institutional holder #2 (13F as filed): Williams Jones Wealth Management, LLC.$10,7462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error
Largest institutional holder #3 (13F as filed): Next Capital Management LLC$5,9702026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error
Largest institutional holder #4 (13F as filed): HORIZON FINANCIAL SERVICES, LLC$4,3462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error
Largest institutional holder #5 (13F as filed): Ancora Advisors LLC$2,2662026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error
Largest institutional holder #6 (13F as filed): CAZ INVESTMENTS LP$1,9102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 05:38 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.